Craig Barbarosh has served on Sabra’s Board of Directors since November 2010. Mr. Barbarosh also currently serves as a Director and Vice Chair of the Board, as Chair of the Compensation Committee and member of the Special Transaction and Nominating and Governance Committees of NextGen Healthcare, Inc. (formerly known as Quality Systems, Inc.), a developer and marketer of healthcare information systems, as a Director and Chair of the Board of Landec Corporation, a diversified health and wellness company, and as a Director and member of the Compensation and Strategy Committees of Evolent Health, Inc., a provider of healthcare information systems. From January 2016 until October 2016, Mr. Barbarosh served as a Director and as Chair of the Nominating and Governance Committee and member of the Audit and Compensation Committees of BioPharmX, Inc., a specialty pharmaceutical company. From September 2017 until its sale in February 2018, Mr. Barbarosh served as a Director and member of the Compensation Committee of Bazaarvoice, Inc., a SaaS-based provider of consumer engagement software to the retail sector. From May 2018 until its sale in July 2019, Mr. Barbarosh served as a Director and member of the Compensation Committee and as Chair of the Strategic Review Committee of Aratana Therapeutics, Inc., a specialty pharmaceutical company. Mr. Barbarosh has been a Partner at the law firm of Katten Muchin Rosenman since June 2012 and is a nationally recognized restructuring expert. Mr. Barbarosh previously served on Katten’s Executive Committee and Board of Directors. From 1999 until joining Katten, Mr. Barbarosh was a Partner at the law firm of Pillsbury Winthrop Shaw Pittman LLP, where he served in several leadership positions including on the firm’s Board of Directors, as Chair of the firm’s Board Strategy Committee, as co-leader of the firm’s national Insolvency and Restructuring practice section and as Managing Partner of the firm’s Orange County, California, office. Additionally, Mr. Barbarosh has completed certificated executive education programs at University of Pennsylvania, The Wharton School, in Corporate Valuation (2019), Harvard Business School in Effective Corporate Boards (2015), Strategic Business Valuation (2010) and Private Equity/Venture Capital (2007) and Carnegie Mellon University in Cybersecurity Oversight (2019).